Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?

Understand how particle size impacts inhalation drug delivery and the role of dry powder inhalers (DPIs) in treating respiratory diseases.
Assessing Particle Size in DPIs with Spraytec & Unidose

Assess setups to combine Spraytec & Unidose™ for evaluating particle size distribution in dry powder inhalers.
Characterizing Nasal Suspensions for Regulatory and Scientific Purposes

Explore Nanopharm’s in-depth research on particle size and its role in in vitro bioequivalence for nasal drug delivery. Discover how particle sizing impacts regulatory compliance and drug efficacy.